Programmable DNA pyrimidine base editing via engineered uracil-DNA glycosylase.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
30 Jul 2024
Historique:
received: 19 03 2024
accepted: 27 06 2024
medline: 31 7 2024
pubmed: 31 7 2024
entrez: 30 7 2024
Statut: epublish

Résumé

DNA base editing technologies predominantly utilize engineered deaminases, limiting their ability to edit thymine and guanine directly. In this study, we successfully achieve base editing of both cytidine and thymine by leveraging the translesion DNA synthesis pathway through the engineering of uracil-DNA glycosylase (UNG). Employing structure-based rational design, exploration of homologous proteins, and mutation screening, we identify a Deinococcus radiodurans UNG mutant capable of effectively editing thymine. When fused with the nickase Cas9, the engineered DrUNG protein facilitates efficient thymine base editing at endogenous sites, achieving editing efficiencies up to 55% without enrichment and exhibiting minimal cellular toxicity. This thymine base editor (TBE) exhibits high editing specificity and significantly restores IDUA enzyme activity in cells derived from patients with Hurler syndrome. TBEs represent efficient, specific, and low-toxicity approaches to base editing with potential applications in treating relevant diseases.

Identifiants

pubmed: 39080265
doi: 10.1038/s41467-024-50012-w
pii: 10.1038/s41467-024-50012-w
doi:

Substances chimiques

Uracil-DNA Glycosidase EC 3.2.2.-
DNA 9007-49-2
Thymine QR26YLT7LT
CRISPR-Associated Protein 9 EC 3.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6397

Subventions

Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : NSFC31930016

Informations de copyright

© 2024. The Author(s).

Références

Porto, E. M., Komor, A. C., Slaymaker, I. M. & Yeo, G. W. Base editing: advances and therapeutic opportunities. Nat. Rev. Drug Discov. 19, 839–859 (2020).
doi: 10.1038/s41573-020-0084-6 pubmed: 33077937 pmcid: 7721651
Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824–844 (2020).
doi: 10.1038/s41587-020-0561-9 pubmed: 32572269
Gaudelli, N. M. et al. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551, 464–471 (2017).
doi: 10.1038/nature24644 pubmed: 29160308 pmcid: 5726555
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016).
doi: 10.1038/nature17946 pubmed: 27096365 pmcid: 4873371
Zhao, D. et al. Glycosylase base editors enable C-to-A and C-to-G base changes. Nat. Biotechnol. 39, 35–40 (2021).
doi: 10.1038/s41587-020-0592-2 pubmed: 32690970
Kurt, I. C. et al. CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells. Nat. Biotechnol. 39, 41–46 (2021).
doi: 10.1038/s41587-020-0609-x pubmed: 32690971
Tong, H. et al. Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase. Nat. Biotechnol. 41, 1080–1084 (2023).
doi: 10.1038/s41587-022-01595-6 pubmed: 36624150
Chen, L. et al. Adenine transversion editors enable precise, efficient A*T-to-C*G base editing in mammalian cells and embryos. Nat. Biotechnol. 42, 638–650 (2024).
Tong, H. et al. Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase. Natl Sci. Rev. 10, nwad143 (2023).
doi: 10.1093/nsr/nwad143 pubmed: 37404457 pmcid: 10317176
Pearl, L. H. Structure and function in the uracil-DNA glycosylase superfamily. Mutat. Res. 460, 165–181 (2000).
doi: 10.1016/S0921-8777(00)00025-2 pubmed: 10946227
Usha, S. & Selvaraj, S. Structure-wise discrimination of cytosine, thymine, and uracil by proteins in terms of their nonbonded interactions. J. Biomol. Struct. Dyn. 32, 1686–1704 (2014).
doi: 10.1080/07391102.2013.832384 pubmed: 24028440
Parikh, S. S. et al. Base excision repair initiation revealed by crystal structures and binding kinetics of human uracil-DNA glycosylase with DNA. EMBO J. 17, 5214–5226 (1998).
doi: 10.1093/emboj/17.17.5214 pubmed: 9724657 pmcid: 1170849
Yi, Z. et al. Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo. Nat. Biotechnol. 40, 946–955 (2022).
doi: 10.1038/s41587-021-01180-3 pubmed: 35145313
Qu, L. et al. Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs. Nat. Biotechnol. 37, 1059–1069 (2019).
doi: 10.1038/s41587-019-0178-z pubmed: 31308540
Kavli, B. et al. Excision of cytosine and thymine from DNA by mutants of human uracil-DNA glycosylase. EMBO J. 15, 3442–3447 (1996).
doi: 10.1002/j.1460-2075.1996.tb00710.x pubmed: 8670846 pmcid: 451908
Duncan, B. K. Isolation of insertion, deletion, and nonsense mutations of the uracil-DNA glycosylase (ung) gene of Escherichia coli K-12. J. Bacteriol. 164, 689–695 (1985).
doi: 10.1128/jb.164.2.689-695.1985 pubmed: 2997126 pmcid: 214307
Leiros, I., Moe, E., Smalas, A. O. & McSweeney, S. Structure of the uracil-DNA N-glycosylase (UNG) from Deinococcus radiodurans. Acta Crystallogr. D. Biol. Crystallogr. 61, 1049–1056 (2005).
doi: 10.1107/S090744490501382X pubmed: 16041069
Krusong, K., Carpenter, E. P., Bellamy, S. R., Savva, R. & Baldwin, G. S. A comparative study of uracil-DNA glycosylases from human and herpes simplex virus type 1. J. Biol. Chem. 281, 4983–4992 (2006).
doi: 10.1074/jbc.M509137200 pubmed: 16306042
Burmeister, W. P. et al. Crystal structure of the vaccinia virus uracil-DNA glycosylase in complex with DNA. J. Biol. Chem. 290, 17923–17934 (2015).
doi: 10.1074/jbc.M115.648352 pubmed: 26045555 pmcid: 4505040
Doman, J. L., Raguram, A., Newby, G. A. & Liu, D. R. Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nat. Biotechnol. 38, 620–628 (2020).
doi: 10.1038/s41587-020-0414-6 pubmed: 32042165 pmcid: 7335424
Ye, L. et al. Glycosylase-based base editors for efficient T-to-G and C-to-G editing in mammalian cells. Nat. Biotechnol. (2024). Online ahead of print.
He, Y. et al. Protein language models-assisted optimization of a uracil-N-glycosylase variant enables programmable T-to-G and T-to-C base editing. Mol. Cell 84, 1257–1270.e6 (2024).
Hibshman, G. N. et al. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9. Nat. Commun. 15, 3663 (2024).
doi: 10.1038/s41467-024-47830-3 pubmed: 38688943 pmcid: 11061278
Yi, Z. et al. Utilizing AAV-mediated LEAPER 2.0 for programmable RNA editing in non-human primates and nonsense mutation correction in humanized Hurler syndrome mice. Genome Biol. 24, 243 (2023).
doi: 10.1186/s13059-023-03086-6 pubmed: 37872590 pmcid: 10591355
Picardi, E. & Pesole, G. REDItools: high-throughput RNA editing detection made easy. Bioinformatics 29, 1813–1814 (2013).
doi: 10.1093/bioinformatics/btt287 pubmed: 23742983

Auteurs

Zongyi Yi (Z)

Biomedical Pioneering Innovation Center, Peking-Tsinghua Center for Life Sciences, Peking University Genome Editing Research Center, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, People's Republic of China.

Xiaoxue Zhang (X)

Changping Laboratory, Beijing, People's Republic of China.

Xiaoxu Wei (X)

Biomedical Pioneering Innovation Center, Peking-Tsinghua Center for Life Sciences, Peking University Genome Editing Research Center, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, People's Republic of China.
Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, People's Republic of China.

Jiayi Li (J)

Biomedical Pioneering Innovation Center, Peking-Tsinghua Center for Life Sciences, Peking University Genome Editing Research Center, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, People's Republic of China.
Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, People's Republic of China.

Jiwu Ren (J)

Changping Laboratory, Beijing, People's Republic of China.
Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, People's Republic of China.

Xue Zhang (X)

Changping Laboratory, Beijing, People's Republic of China.

Yike Zhang (Y)

Biomedical Pioneering Innovation Center, Peking-Tsinghua Center for Life Sciences, Peking University Genome Editing Research Center, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, People's Republic of China.
Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, People's Republic of China.

Huixian Tang (H)

Biomedical Pioneering Innovation Center, Peking-Tsinghua Center for Life Sciences, Peking University Genome Editing Research Center, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, People's Republic of China.
Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, People's Republic of China.

Xiwen Chang (X)

Changping Laboratory, Beijing, People's Republic of China.
Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, People's Republic of China.

Ying Yu (Y)

Biomedical Pioneering Innovation Center, Peking-Tsinghua Center for Life Sciences, Peking University Genome Editing Research Center, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, People's Republic of China.

Wensheng Wei (W)

Biomedical Pioneering Innovation Center, Peking-Tsinghua Center for Life Sciences, Peking University Genome Editing Research Center, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, People's Republic of China. wswei@pku.edu.cn.
Changping Laboratory, Beijing, People's Republic of China. wswei@pku.edu.cn.
Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, People's Republic of China. wswei@pku.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH